XML 32 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Changes in Shareholders' Equity
¥ in Thousands, $ in Thousands
Ordinary Shares
Class A
Adjusted
CNY (¥)
shares
Ordinary Shares
Class A
CNY (¥)
shares
Ordinary Shares
Class B
Adjusted
CNY (¥)
shares
Ordinary Shares
Class B
CNY (¥)
shares
Additional Paid-in Capital
Adjusted
CNY (¥)
Additional Paid-in Capital
CNY (¥)
Statutory reserves
Adjusted
CNY (¥)
Statutory reserves
CNY (¥)
Accumulated other comprehensive loss
Adjusted
CNY (¥)
Accumulated other comprehensive loss
CNY (¥)
Accumulated deficit
Adjusted
CNY (¥)
Accumulated deficit
CNY (¥)
Non- controlling interests
Adjusted
CNY (¥)
Non- controlling interests
CNY (¥)
Receivable for issuance of ordinary shares
Adjusted
CNY (¥)
Receivable for issuance of ordinary shares
CNY (¥)
Adjusted
CNY (¥)
CNY (¥)
shares
USD ($)
shares
Balances at Mar. 31, 2022   ¥ 372   ¥ 82   ¥ 3,295,336   ¥ 3,433   ¥ (46,069)   ¥ (2,889,233)   ¥ 42,648   ¥ (164,746)   ¥ 241,823  
Balances (in Shares) at Mar. 31, 2022 | shares   55,709,591   13,037,729                              
Foreign currency translation adjustment           15,591         15,591  
Accretion on redeemable non-controlling interests to redemption value             (675)       (675)  
Receivable for issuance of ordinary shares (Note 21)                 81,341   81,341  
Unrealized securities holding gains, net of tax           (6,711)         (6,711)  
Issuance of ordinary shares for the exercise of stock options   ¥ 1     37             38  
Issuance of ordinary shares for the exercise of stock options (in Shares) | shares   53,488                                
Appropriations to statutory reserves         443     (443)        
Share-based compensation       (7,677)             (7,677)  
Net loss             (102,799)   (3,177)     (105,976)  
Balances at Mar. 31, 2023 ¥ 373 ¥ 373 ¥ 82 ¥ 82 ¥ 3,287,696 3,287,696 ¥ 3,876 3,876 ¥ (37,189) (37,189) ¥ (2,995,975) (2,993,150) ¥ 39,471 39,471 ¥ (83,405) (83,405) ¥ 214,929 217,754  
Balances (in Shares) at Mar. 31, 2023 | shares 55,763,079 55,763,079 13,037,729 13,037,729                              
Change in Accounting Policy   [1]   [1]   [1]   [1]   [1]   (2,825) [1]   [1]   [1]   (2,825)  
Foreign currency translation adjustment           1,258         1,258  
Accretion on redeemable non-controlling interests to redemption value             (766)       (766)  
Receivable for issuance of ordinary shares (Note 21)       75,276           (7,902)   67,374  
Unrealized securities holding gains, net of tax           (3,547)         (3,547)  
Issuance of ordinary shares for the exercise of stock options       27             ¥ 27  
Issuance of ordinary shares for the exercise of stock options (in Shares) | shares   9,428,674                             37,741 37,741
Share-based compensation       679             ¥ 679  
Debt waive of Chong Li       (75,276)           75,276    
Issuance of ordinary shares for the private placement (Note 18)   ¥ 589     41,273             41,862  
Issuance of ordinary shares for the private placement (Note 18) (in Shares) | shares   82,500,000                                
Net loss             (63,664)   (5,234)     (68,898)  
Balances at Mar. 31, 2024   ¥ 962   ¥ 82   3,329,675   3,876   (39,478)   (3,060,405)   34,237   (16,031)   252,918  
Balances (in Shares) at Mar. 31, 2024 | shares   147,691,753   13,037,729                              
Foreign currency translation adjustment           840         840 $ 116
Accretion on redeemable non-controlling interests to redemption value             (841)       (841)  
Receivable for issuance of ordinary shares (Note 21)                 9,783   9,783  
Unrealized securities holding gains, net of tax           869         ¥ 869 $ 120
Issuance of ordinary shares for the exercise of stock options (in Shares) | shares                                  
Share-based compensation       81             ¥ 81  
Issuance of ordinary shares for the private placement (Note 18)   ¥ 2,152     12,365             14,517  
Issuance of ordinary shares for the private placement (Note 18) (in Shares) | shares   300,000,000                                
Net loss             (54,125)   (4,471)     (58,596) $ (8,076)
Balances at Mar. 31, 2025   ¥ 3,114   ¥ 82   ¥ 3,342,121   ¥ 3,876   ¥ (37,769)   ¥ (3,115,371)   ¥ 29,766   ¥ (6,248)   ¥ 219,571 $ 30,257
Balances (in Shares) at Mar. 31, 2025 | shares   447,691,753   13,037,729                              
[1] The Company used a modified retrospective approach to adopt ASC Topic 326, and the cumulative-effect to retained earnings was RMB2.8 million